Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boyu Capital is one of the leading private equity and alternative asset management firms in China and Asia-Pacific. Founded in 2010/2011 by Alvin Jiang and other prominent investors, the firm focuses on private equity, public equities, real assets & infrastructure, venture capital, and renewable energy investments. It has built a reputation for investing in high-growth sectors including technology, consumer & retail, and healthcare. The firm has participated in major deals such as Alibaba Group’s IPO and Ant Group’s pre-IPO rounds. As of 2022 its assets under management were reported at approximately $40 billion USD.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boyu Capital.